Global Drugs of Abuse Analysis Controls Production, Demand and Key Producers, 2022-2028
This report studies the global Drugs of Abuse Analysis Controls production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drugs of Abuse Analysis Controls, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs of Abuse Analysis Controls that contribute to its increasing demand across many markets.
The global Drugs of Abuse Analysis Controls market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Drugs of Abuse Analysis Controls total production and demand, 2017-2028, (K Units)
Global Drugs of Abuse Analysis Controls total production value, 2017-2028, (USD Million)
Global Drugs of Abuse Analysis Controls production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drugs of Abuse Analysis Controls consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Drugs of Abuse Analysis Controls domestic production, consumption, key domestic manufacturers and share
Global Drugs of Abuse Analysis Controls production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Drugs of Abuse Analysis Controls production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drugs of Abuse Analysis Controls production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Drugs of Abuse Analysis Controls market based on the following parameters – headquarters, production locations, products portfolio, Drugs of Abuse Analysis Controls revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drugs of Abuse Analysis Controls market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Drugs of Abuse Analysis Controls Market, By Region:
1. How big is the global Drugs of Abuse Analysis Controls market?
2. What is the demand of the global Drugs of Abuse Analysis Controls market?
3. What is the year over year growth of the global Drugs of Abuse Analysis Controls market?
4. What is the production and production value of the global Drugs of Abuse Analysis Controls market?
5. Who are the key producers in the global Drugs of Abuse Analysis Controls market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Drugs of Abuse Analysis Controls, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs of Abuse Analysis Controls that contribute to its increasing demand across many markets.
The global Drugs of Abuse Analysis Controls market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Drugs of Abuse Analysis Controls total production and demand, 2017-2028, (K Units)
Global Drugs of Abuse Analysis Controls total production value, 2017-2028, (USD Million)
Global Drugs of Abuse Analysis Controls production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drugs of Abuse Analysis Controls consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Drugs of Abuse Analysis Controls domestic production, consumption, key domestic manufacturers and share
Global Drugs of Abuse Analysis Controls production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Drugs of Abuse Analysis Controls production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Drugs of Abuse Analysis Controls production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Drugs of Abuse Analysis Controls market based on the following parameters – headquarters, production locations, products portfolio, Drugs of Abuse Analysis Controls revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drugs of Abuse Analysis Controls market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Drugs of Abuse Analysis Controls Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Liquid
- Lyophilized
- Others
- Hospital
- Clinical
- Diagnostic Laboratories
- Others
- Siemens
- Abbott
- QuidelOrtho Corporation
- Thermo Fisher Scientific
- Horiba
- Beckman Coulter
- Ortho Clinical Diagnostics
- Microgenics
- MedTest DX
- Carolina Liquid Chemistries
- Cerilliant
- American Bio Medica Corp
- Clarity Diagnostics LLC
- Diatron
- Kova International
- Lin-Zhi International Inc
- JAS Diagnostics
- Quasar Instruments
- BTNX
- Bio-Rad Laboratories
1. How big is the global Drugs of Abuse Analysis Controls market?
2. What is the demand of the global Drugs of Abuse Analysis Controls market?
3. What is the year over year growth of the global Drugs of Abuse Analysis Controls market?
4. What is the production and production value of the global Drugs of Abuse Analysis Controls market?
5. Who are the key producers in the global Drugs of Abuse Analysis Controls market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Drugs of Abuse Analysis Controls Introduction
1.2 World Drugs of Abuse Analysis Controls Supply & Forecast
1.2.1 World Drugs of Abuse Analysis Controls Production Value (2017 & 2021 & 2028)
1.2.2 World Drugs of Abuse Analysis Controls Production (2017-2028)
1.2.3 World Drugs of Abuse Analysis Controls Pricing Trends (2017-2028)
1.3 World Drugs of Abuse Analysis Controls Production by Region
1.3.1 World Drugs of Abuse Analysis Controls Production Value by Region (2017-2028)
1.3.2 World Drugs of Abuse Analysis Controls Production by Region (2017-2028)
1.3.3 World Drugs of Abuse Analysis Controls Average Price by Region (2017-2028)
1.3.4 North America Drugs of Abuse Analysis Controls Production (2017-2028)
1.3.5 Europe Drugs of Abuse Analysis Controls Production (2017-2028)
1.3.6 China Drugs of Abuse Analysis Controls Production (2017-2028)
1.3.7 Japan Drugs of Abuse Analysis Controls Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drugs of Abuse Analysis Controls Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drugs of Abuse Analysis Controls Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Drugs of Abuse Analysis Controls Demand (2017-2028)
2.2 World Drugs of Abuse Analysis Controls Consumption by Region
2.2.1 World Drugs of Abuse Analysis Controls Consumption by Region (2017-2022)
2.2.2 World Drugs of Abuse Analysis Controls Consumption Forecast by Region (2023-2028)
2.3 United States Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.4 China Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.5 Europe Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.6 Japan Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.7 South Korea Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.8 ASEAN Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.9 India Drugs of Abuse Analysis Controls Consumption (2017-2028)
3 WORLD DRUGS OF ABUSE ANALYSIS CONTROLS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Drugs of Abuse Analysis Controls Production Value by Manufacturer (2017-2022)
3.2 World Drugs of Abuse Analysis Controls Production by Manufacturer (2017-2022)
3.3 World Drugs of Abuse Analysis Controls Average Price by Manufacturer (2017-2022)
3.4 Drugs of Abuse Analysis Controls Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drugs of Abuse Analysis Controls Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drugs of Abuse Analysis Controls in 2021
3.5.3 Global Concentration Ratios (CR8) for Drugs of Abuse Analysis Controls in 2021
3.6 Drugs of Abuse Analysis Controls Market: Overall Company Footprint Analysis
3.6.1 Drugs of Abuse Analysis Controls Market: Region Footprint
3.6.2 Drugs of Abuse Analysis Controls Market: Company Product Type Footprint
3.6.3 Drugs of Abuse Analysis Controls Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Drugs of Abuse Analysis Controls Production Value Comparison
4.1.1 United States VS China: Drugs of Abuse Analysis Controls Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Drugs of Abuse Analysis Controls Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Drugs of Abuse Analysis Controls Production Comparison
4.2.1 United States VS China: Drugs of Abuse Analysis Controls Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Drugs of Abuse Analysis Controls Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Drugs of Abuse Analysis Controls Consumption Comparison
4.3.1 United States VS China: Drugs of Abuse Analysis Controls Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Drugs of Abuse Analysis Controls Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Drugs of Abuse Analysis Controls Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Drugs of Abuse Analysis Controls in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022)
4.5 China Drugs of Abuse Analysis Controls Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Drugs of Abuse Analysis Controls in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Drugs of Abuse Analysis Controls Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Drugs of Abuse Analysis Controls in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Drugs of Abuse Analysis Controls Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Liquid
5.2.2 Lyophilized
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Drugs of Abuse Analysis Controls Production by Type (2017-2028)
5.3.2 World Drugs of Abuse Analysis Controls Production Value by Type (2017-2028)
5.3.3 World Drugs of Abuse Analysis Controls Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drugs of Abuse Analysis Controls Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinical
6.2.3 Diagnostic Laboratories
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Drugs of Abuse Analysis Controls Production by Application (2017-2028)
6.3.2 World Drugs of Abuse Analysis Controls Production Value by Application (2017-2028)
6.3.3 World Drugs of Abuse Analysis Controls Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Siemens
7.1.1 Siemens Details
7.1.2 Siemens Major Business
7.1.3 Siemens Drugs of Abuse Analysis Controls Product and Services
7.1.4 Siemens Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Siemens Recent Developments/Updates
7.1.6 Siemens Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Drugs of Abuse Analysis Controls Product and Services
7.2.4 Abbott Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 QuidelOrtho Corporation
7.3.1 QuidelOrtho Corporation Details
7.3.2 QuidelOrtho Corporation Major Business
7.3.3 QuidelOrtho Corporation Drugs of Abuse Analysis Controls Product and Services
7.3.4 QuidelOrtho Corporation Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 QuidelOrtho Corporation Recent Developments/Updates
7.3.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Drugs of Abuse Analysis Controls Product and Services
7.4.4 Thermo Fisher Scientific Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Horiba
7.5.1 Horiba Details
7.5.2 Horiba Major Business
7.5.3 Horiba Drugs of Abuse Analysis Controls Product and Services
7.5.4 Horiba Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Horiba Recent Developments/Updates
7.5.6 Horiba Competitive Strengths & Weaknesses
7.6 Beckman Coulter
7.6.1 Beckman Coulter Details
7.6.2 Beckman Coulter Major Business
7.6.3 Beckman Coulter Drugs of Abuse Analysis Controls Product and Services
7.6.4 Beckman Coulter Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Beckman Coulter Recent Developments/Updates
7.6.6 Beckman Coulter Competitive Strengths & Weaknesses
7.7 Ortho Clinical Diagnostics
7.7.1 Ortho Clinical Diagnostics Details
7.7.2 Ortho Clinical Diagnostics Major Business
7.7.3 Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Product and Services
7.7.4 Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Ortho Clinical Diagnostics Recent Developments/Updates
7.7.6 Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
7.8 Microgenics
7.8.1 Microgenics Details
7.8.2 Microgenics Major Business
7.8.3 Microgenics Drugs of Abuse Analysis Controls Product and Services
7.8.4 Microgenics Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Microgenics Recent Developments/Updates
7.8.6 Microgenics Competitive Strengths & Weaknesses
7.9 MedTest DX
7.9.1 MedTest DX Details
7.9.2 MedTest DX Major Business
7.9.3 MedTest DX Drugs of Abuse Analysis Controls Product and Services
7.9.4 MedTest DX Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 MedTest DX Recent Developments/Updates
7.9.6 MedTest DX Competitive Strengths & Weaknesses
7.10 Carolina Liquid Chemistries
7.10.1 Carolina Liquid Chemistries Details
7.10.2 Carolina Liquid Chemistries Major Business
7.10.3 Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Product and Services
7.10.4 Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Carolina Liquid Chemistries Recent Developments/Updates
7.10.6 Carolina Liquid Chemistries Competitive Strengths & Weaknesses
7.11 Cerilliant
7.11.1 Cerilliant Details
7.11.2 Cerilliant Major Business
7.11.3 Cerilliant Drugs of Abuse Analysis Controls Product and Services
7.11.4 Cerilliant Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Cerilliant Recent Developments/Updates
7.11.6 Cerilliant Competitive Strengths & Weaknesses
7.12 American Bio Medica Corp
7.12.1 American Bio Medica Corp Details
7.12.2 American Bio Medica Corp Major Business
7.12.3 American Bio Medica Corp Drugs of Abuse Analysis Controls Product and Services
7.12.4 American Bio Medica Corp Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 American Bio Medica Corp Recent Developments/Updates
7.12.6 American Bio Medica Corp Competitive Strengths & Weaknesses
7.13 Clarity Diagnostics LLC
7.13.1 Clarity Diagnostics LLC Details
7.13.2 Clarity Diagnostics LLC Major Business
7.13.3 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Product and Services
7.13.4 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Clarity Diagnostics LLC Recent Developments/Updates
7.13.6 Clarity Diagnostics LLC Competitive Strengths & Weaknesses
7.14 Diatron
7.14.1 Diatron Details
7.14.2 Diatron Major Business
7.14.3 Diatron Drugs of Abuse Analysis Controls Product and Services
7.14.4 Diatron Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Diatron Recent Developments/Updates
7.14.6 Diatron Competitive Strengths & Weaknesses
7.15 Kova International
7.15.1 Kova International Details
7.15.2 Kova International Major Business
7.15.3 Kova International Drugs of Abuse Analysis Controls Product and Services
7.15.4 Kova International Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Kova International Recent Developments/Updates
7.15.6 Kova International Competitive Strengths & Weaknesses
7.16 Lin-Zhi International Inc
7.16.1 Lin-Zhi International Inc Details
7.16.2 Lin-Zhi International Inc Major Business
7.16.3 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Product and Services
7.16.4 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Lin-Zhi International Inc Recent Developments/Updates
7.16.6 Lin-Zhi International Inc Competitive Strengths & Weaknesses
7.17 JAS Diagnostics
7.17.1 JAS Diagnostics Details
7.17.2 JAS Diagnostics Major Business
7.17.3 JAS Diagnostics Drugs of Abuse Analysis Controls Product and Services
7.17.4 JAS Diagnostics Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 JAS Diagnostics Recent Developments/Updates
7.17.6 JAS Diagnostics Competitive Strengths & Weaknesses
7.18 Quasar Instruments
7.18.1 Quasar Instruments Details
7.18.2 Quasar Instruments Major Business
7.18.3 Quasar Instruments Drugs of Abuse Analysis Controls Product and Services
7.18.4 Quasar Instruments Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 Quasar Instruments Recent Developments/Updates
7.18.6 Quasar Instruments Competitive Strengths & Weaknesses
7.19 BTNX
7.19.1 BTNX Details
7.19.2 BTNX Major Business
7.19.3 BTNX Drugs of Abuse Analysis Controls Product and Services
7.19.4 BTNX Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 BTNX Recent Developments/Updates
7.19.6 BTNX Competitive Strengths & Weaknesses
7.20 Bio-Rad Laboratories
7.20.1 Bio-Rad Laboratories Details
7.20.2 Bio-Rad Laboratories Major Business
7.20.3 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Product and Services
7.20.4 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Bio-Rad Laboratories Recent Developments/Updates
7.20.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Drugs of Abuse Analysis Controls and Key Manufacturers
8.2 Drugs of Abuse Analysis Controls Manufacturing Costs
8.3 Drugs of Abuse Analysis Controls Production Process
8.4 Drugs of Abuse Analysis Controls Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Drugs of Abuse Analysis Controls Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Drugs of Abuse Analysis Controls Typical Distributors
9.3 Drugs of Abuse Analysis Controls Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Drugs of Abuse Analysis Controls Introduction
1.2 World Drugs of Abuse Analysis Controls Supply & Forecast
1.2.1 World Drugs of Abuse Analysis Controls Production Value (2017 & 2021 & 2028)
1.2.2 World Drugs of Abuse Analysis Controls Production (2017-2028)
1.2.3 World Drugs of Abuse Analysis Controls Pricing Trends (2017-2028)
1.3 World Drugs of Abuse Analysis Controls Production by Region
1.3.1 World Drugs of Abuse Analysis Controls Production Value by Region (2017-2028)
1.3.2 World Drugs of Abuse Analysis Controls Production by Region (2017-2028)
1.3.3 World Drugs of Abuse Analysis Controls Average Price by Region (2017-2028)
1.3.4 North America Drugs of Abuse Analysis Controls Production (2017-2028)
1.3.5 Europe Drugs of Abuse Analysis Controls Production (2017-2028)
1.3.6 China Drugs of Abuse Analysis Controls Production (2017-2028)
1.3.7 Japan Drugs of Abuse Analysis Controls Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drugs of Abuse Analysis Controls Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drugs of Abuse Analysis Controls Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Drugs of Abuse Analysis Controls Demand (2017-2028)
2.2 World Drugs of Abuse Analysis Controls Consumption by Region
2.2.1 World Drugs of Abuse Analysis Controls Consumption by Region (2017-2022)
2.2.2 World Drugs of Abuse Analysis Controls Consumption Forecast by Region (2023-2028)
2.3 United States Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.4 China Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.5 Europe Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.6 Japan Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.7 South Korea Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.8 ASEAN Drugs of Abuse Analysis Controls Consumption (2017-2028)
2.9 India Drugs of Abuse Analysis Controls Consumption (2017-2028)
3 WORLD DRUGS OF ABUSE ANALYSIS CONTROLS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Drugs of Abuse Analysis Controls Production Value by Manufacturer (2017-2022)
3.2 World Drugs of Abuse Analysis Controls Production by Manufacturer (2017-2022)
3.3 World Drugs of Abuse Analysis Controls Average Price by Manufacturer (2017-2022)
3.4 Drugs of Abuse Analysis Controls Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drugs of Abuse Analysis Controls Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drugs of Abuse Analysis Controls in 2021
3.5.3 Global Concentration Ratios (CR8) for Drugs of Abuse Analysis Controls in 2021
3.6 Drugs of Abuse Analysis Controls Market: Overall Company Footprint Analysis
3.6.1 Drugs of Abuse Analysis Controls Market: Region Footprint
3.6.2 Drugs of Abuse Analysis Controls Market: Company Product Type Footprint
3.6.3 Drugs of Abuse Analysis Controls Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Drugs of Abuse Analysis Controls Production Value Comparison
4.1.1 United States VS China: Drugs of Abuse Analysis Controls Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Drugs of Abuse Analysis Controls Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Drugs of Abuse Analysis Controls Production Comparison
4.2.1 United States VS China: Drugs of Abuse Analysis Controls Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Drugs of Abuse Analysis Controls Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Drugs of Abuse Analysis Controls Consumption Comparison
4.3.1 United States VS China: Drugs of Abuse Analysis Controls Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Drugs of Abuse Analysis Controls Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Drugs of Abuse Analysis Controls Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Drugs of Abuse Analysis Controls in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022)
4.5 China Drugs of Abuse Analysis Controls Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Drugs of Abuse Analysis Controls in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Drugs of Abuse Analysis Controls Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Drugs of Abuse Analysis Controls in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Drugs of Abuse Analysis Controls Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Liquid
5.2.2 Lyophilized
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Drugs of Abuse Analysis Controls Production by Type (2017-2028)
5.3.2 World Drugs of Abuse Analysis Controls Production Value by Type (2017-2028)
5.3.3 World Drugs of Abuse Analysis Controls Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drugs of Abuse Analysis Controls Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinical
6.2.3 Diagnostic Laboratories
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Drugs of Abuse Analysis Controls Production by Application (2017-2028)
6.3.2 World Drugs of Abuse Analysis Controls Production Value by Application (2017-2028)
6.3.3 World Drugs of Abuse Analysis Controls Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Siemens
7.1.1 Siemens Details
7.1.2 Siemens Major Business
7.1.3 Siemens Drugs of Abuse Analysis Controls Product and Services
7.1.4 Siemens Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Siemens Recent Developments/Updates
7.1.6 Siemens Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Drugs of Abuse Analysis Controls Product and Services
7.2.4 Abbott Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 QuidelOrtho Corporation
7.3.1 QuidelOrtho Corporation Details
7.3.2 QuidelOrtho Corporation Major Business
7.3.3 QuidelOrtho Corporation Drugs of Abuse Analysis Controls Product and Services
7.3.4 QuidelOrtho Corporation Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 QuidelOrtho Corporation Recent Developments/Updates
7.3.6 QuidelOrtho Corporation Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Drugs of Abuse Analysis Controls Product and Services
7.4.4 Thermo Fisher Scientific Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Horiba
7.5.1 Horiba Details
7.5.2 Horiba Major Business
7.5.3 Horiba Drugs of Abuse Analysis Controls Product and Services
7.5.4 Horiba Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Horiba Recent Developments/Updates
7.5.6 Horiba Competitive Strengths & Weaknesses
7.6 Beckman Coulter
7.6.1 Beckman Coulter Details
7.6.2 Beckman Coulter Major Business
7.6.3 Beckman Coulter Drugs of Abuse Analysis Controls Product and Services
7.6.4 Beckman Coulter Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Beckman Coulter Recent Developments/Updates
7.6.6 Beckman Coulter Competitive Strengths & Weaknesses
7.7 Ortho Clinical Diagnostics
7.7.1 Ortho Clinical Diagnostics Details
7.7.2 Ortho Clinical Diagnostics Major Business
7.7.3 Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Product and Services
7.7.4 Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Ortho Clinical Diagnostics Recent Developments/Updates
7.7.6 Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
7.8 Microgenics
7.8.1 Microgenics Details
7.8.2 Microgenics Major Business
7.8.3 Microgenics Drugs of Abuse Analysis Controls Product and Services
7.8.4 Microgenics Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Microgenics Recent Developments/Updates
7.8.6 Microgenics Competitive Strengths & Weaknesses
7.9 MedTest DX
7.9.1 MedTest DX Details
7.9.2 MedTest DX Major Business
7.9.3 MedTest DX Drugs of Abuse Analysis Controls Product and Services
7.9.4 MedTest DX Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 MedTest DX Recent Developments/Updates
7.9.6 MedTest DX Competitive Strengths & Weaknesses
7.10 Carolina Liquid Chemistries
7.10.1 Carolina Liquid Chemistries Details
7.10.2 Carolina Liquid Chemistries Major Business
7.10.3 Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Product and Services
7.10.4 Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Carolina Liquid Chemistries Recent Developments/Updates
7.10.6 Carolina Liquid Chemistries Competitive Strengths & Weaknesses
7.11 Cerilliant
7.11.1 Cerilliant Details
7.11.2 Cerilliant Major Business
7.11.3 Cerilliant Drugs of Abuse Analysis Controls Product and Services
7.11.4 Cerilliant Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Cerilliant Recent Developments/Updates
7.11.6 Cerilliant Competitive Strengths & Weaknesses
7.12 American Bio Medica Corp
7.12.1 American Bio Medica Corp Details
7.12.2 American Bio Medica Corp Major Business
7.12.3 American Bio Medica Corp Drugs of Abuse Analysis Controls Product and Services
7.12.4 American Bio Medica Corp Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 American Bio Medica Corp Recent Developments/Updates
7.12.6 American Bio Medica Corp Competitive Strengths & Weaknesses
7.13 Clarity Diagnostics LLC
7.13.1 Clarity Diagnostics LLC Details
7.13.2 Clarity Diagnostics LLC Major Business
7.13.3 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Product and Services
7.13.4 Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Clarity Diagnostics LLC Recent Developments/Updates
7.13.6 Clarity Diagnostics LLC Competitive Strengths & Weaknesses
7.14 Diatron
7.14.1 Diatron Details
7.14.2 Diatron Major Business
7.14.3 Diatron Drugs of Abuse Analysis Controls Product and Services
7.14.4 Diatron Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Diatron Recent Developments/Updates
7.14.6 Diatron Competitive Strengths & Weaknesses
7.15 Kova International
7.15.1 Kova International Details
7.15.2 Kova International Major Business
7.15.3 Kova International Drugs of Abuse Analysis Controls Product and Services
7.15.4 Kova International Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Kova International Recent Developments/Updates
7.15.6 Kova International Competitive Strengths & Weaknesses
7.16 Lin-Zhi International Inc
7.16.1 Lin-Zhi International Inc Details
7.16.2 Lin-Zhi International Inc Major Business
7.16.3 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Product and Services
7.16.4 Lin-Zhi International Inc Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Lin-Zhi International Inc Recent Developments/Updates
7.16.6 Lin-Zhi International Inc Competitive Strengths & Weaknesses
7.17 JAS Diagnostics
7.17.1 JAS Diagnostics Details
7.17.2 JAS Diagnostics Major Business
7.17.3 JAS Diagnostics Drugs of Abuse Analysis Controls Product and Services
7.17.4 JAS Diagnostics Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 JAS Diagnostics Recent Developments/Updates
7.17.6 JAS Diagnostics Competitive Strengths & Weaknesses
7.18 Quasar Instruments
7.18.1 Quasar Instruments Details
7.18.2 Quasar Instruments Major Business
7.18.3 Quasar Instruments Drugs of Abuse Analysis Controls Product and Services
7.18.4 Quasar Instruments Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 Quasar Instruments Recent Developments/Updates
7.18.6 Quasar Instruments Competitive Strengths & Weaknesses
7.19 BTNX
7.19.1 BTNX Details
7.19.2 BTNX Major Business
7.19.3 BTNX Drugs of Abuse Analysis Controls Product and Services
7.19.4 BTNX Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 BTNX Recent Developments/Updates
7.19.6 BTNX Competitive Strengths & Weaknesses
7.20 Bio-Rad Laboratories
7.20.1 Bio-Rad Laboratories Details
7.20.2 Bio-Rad Laboratories Major Business
7.20.3 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Product and Services
7.20.4 Bio-Rad Laboratories Drugs of Abuse Analysis Controls Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Bio-Rad Laboratories Recent Developments/Updates
7.20.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Drugs of Abuse Analysis Controls and Key Manufacturers
8.2 Drugs of Abuse Analysis Controls Manufacturing Costs
8.3 Drugs of Abuse Analysis Controls Production Process
8.4 Drugs of Abuse Analysis Controls Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Drugs of Abuse Analysis Controls Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Drugs of Abuse Analysis Controls Typical Distributors
9.3 Drugs of Abuse Analysis Controls Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Drugs of Abuse Analysis Controls Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Drugs of Abuse Analysis Controls Production Value by Region (2017-2022) & (USD Million)
Table 3. World Drugs of Abuse Analysis Controls Production Value by Region (2023-2028) & (USD Million)
Table 4. World Drugs of Abuse Analysis Controls Production Value Market Share by Region (2017-2022)
Table 5. World Drugs of Abuse Analysis Controls Production Value Market Share by Region (2023-2028)
Table 6. World Drugs of Abuse Analysis Controls Production by Region (2017-2022) & (K Units)
Table 7. World Drugs of Abuse Analysis Controls Production by Region (2023-2028) & (K Units)
Table 8. World Drugs of Abuse Analysis Controls Production Market Share by Region (2017-2022)
Table 9. World Drugs of Abuse Analysis Controls Production Market Share by Region (2023-2028)
Table 10. World Drugs of Abuse Analysis Controls Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Drugs of Abuse Analysis Controls Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Drugs of Abuse Analysis Controls Major Market Trends
Table 13. World Drugs of Abuse Analysis Controls Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Drugs of Abuse Analysis Controls Consumption by Region (2017-2022) & (K Units)
Table 15. World Drugs of Abuse Analysis Controls Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Drugs of Abuse Analysis Controls Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Drugs of Abuse Analysis Controls Producers in 2021
Table 18. World Drugs of Abuse Analysis Controls Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Drugs of Abuse Analysis Controls Producers in 2021
Table 20. World Drugs of Abuse Analysis Controls Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Drugs of Abuse Analysis Controls Company Evaluation Quadrant
Table 22. World Drugs of Abuse Analysis Controls Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Drugs of Abuse Analysis Controls Production Site of Key Manufacturer
Table 24. Drugs of Abuse Analysis Controls Market: Company Product Type Footprint
Table 25. Drugs of Abuse Analysis Controls Market: Company Product Application Footprint
Table 26. Drugs of Abuse Analysis Controls Competitive Factors
Table 27. Drugs of Abuse Analysis Controls New Entrant and Capacity Expansion Plans
Table 28. Drugs of Abuse Analysis Controls Mergers & Acquisitions Activity
Table 29. United States VS China Drugs of Abuse Analysis Controls Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Drugs of Abuse Analysis Controls Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Drugs of Abuse Analysis Controls Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Drugs of Abuse Analysis Controls in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Drugs of Abuse Analysis Controls Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Drugs of Abuse Analysis Controls Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Drugs of Abuse Analysis Controls in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Drugs of Abuse Analysis Controls Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Drugs of Abuse Analysis Controls Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Drugs of Abuse Analysis Controls in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Drugs of Abuse Analysis Controls Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Drugs of Abuse Analysis Controls Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Drugs of Abuse Analysis Controls Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Drugs of Abuse Analysis Controls Production by Type (2017-2022) & (K Units)
Table 49. World Drugs of Abuse Analysis Controls Production by Type (2023-2028) & (K Units)
Table 50. World Drugs of Abuse Analysis Controls Production Value by Type (2017-2022) & (USD Million)
Table 51. World Drugs of Abuse Analysis Controls Production Value by Type (2023-2028) & (USD Million)
Table 52. World Drugs of Abuse Analysis Controls Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Drugs of Abuse Analysis Controls Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Drugs of Abuse Analysis Controls Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Drugs of Abuse Analysis Controls Production by Application (2017-2022) & (K Units)
Table 56. World Drugs of Abuse Analysis Controls Production by Application (2023-2028) & (K Units)
Table 57. World Drugs of Abuse Analysis Controls Production Value by Application (2017-2022) & (USD Million)
Table 58. World Drugs of Abuse Analysis Controls Production Value by Application (2023-2028) & (USD Million)
Table 59. World Drugs of Abuse Analysis Controls Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Drugs of Abuse Analysis Controls Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Siemens Basic Information, Manufacturing Base and Competitors
Table 62. Siemens Major Business
Table 63. Siemens Drugs of Abuse Analysis Controls Product and Services
Table 64. Siemens Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Siemens Recent Developments/Updates
Table 66. Siemens Competitive Strengths & Weaknesses
Table 67. Abbott Basic Information, Manufacturing Base and Competitors
Table 68. Abbott Major Business
Table 69. Abbott Drugs of Abuse Analysis Controls Product and Services
Table 70. Abbott Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Abbott Recent Developments/Updates
Table 72. Abbott Competitive Strengths & Weaknesses
Table 73. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 74. QuidelOrtho Corporation Major Business
Table 75. QuidelOrtho Corporation Drugs of Abuse Analysis Controls Product and Services
Table 76. QuidelOrtho Corporation Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. QuidelOrtho Corporation Recent Developments/Updates
Table 78. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 79. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 80. Thermo Fisher Scientific Major Business
Table 81. Thermo Fisher Scientific Drugs of Abuse Analysis Controls Product and Services
Table 82. Thermo Fisher Scientific Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Thermo Fisher Scientific Recent Developments/Updates
Table 84. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 85. Horiba Basic Information, Manufacturing Base and Competitors
Table 86. Horiba Major Business
Table 87. Horiba Drugs of Abuse Analysis Controls Product and Services
Table 88. Horiba Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Horiba Recent Developments/Updates
Table 90. Horiba Competitive Strengths & Weaknesses
Table 91. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 92. Beckman Coulter Major Business
Table 93. Beckman Coulter Drugs of Abuse Analysis Controls Product and Services
Table 94. Beckman Coulter Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Beckman Coulter Recent Developments/Updates
Table 96. Beckman Coulter Competitive Strengths & Weaknesses
Table 97. Ortho Clinical Diagnostics Basic Information, Manufacturing Base and Competitors
Table 98. Ortho Clinical Diagnostics Major Business
Table 99. Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Product and Services
Table 100. Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Ortho Clinical Diagnostics Recent Developments/Updates
Table 102. Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
Table 103. Microgenics Basic Information, Manufacturing Base and Competitors
Table 104. Microgenics Major Business
Table 105. Microgenics Drugs of Abuse Analysis Controls Product and Services
Table 106. Microgenics Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Microgenics Recent Developments/Updates
Table 108. Microgenics Competitive Strengths & Weaknesses
Table 109. MedTest DX Basic Information, Manufacturing Base and Competitors
Table 110. MedTest DX Major Business
Table 111. MedTest DX Drugs of Abuse Analysis Controls Product and Services
Table 112. MedTest DX Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. MedTest DX Recent Developments/Updates
Table 114. MedTest DX Competitive Strengths & Weaknesses
Table 115. Carolina Liquid Chemistries Basic Information, Manufacturing Base and Competitors
Table 116. Carolina Liquid Chemistries Major Business
Table 117. Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Product and Services
Table 118. Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Carolina Liquid Chemistries Recent Developments/Updates
Table 120. Carolina Liquid Chemistries Competitive Strengths & Weaknesses
Table 121. Cerilliant Basic Information, Manufacturing Base and Competitors
Table 122. Cerilliant Major Business
Table 123. Cerilliant Drugs of Abuse Analysis Controls Product and Services
Table 124. Cerilliant Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Cerilliant Recent Developments/Updates
Table 126. Cerilliant Competitive Strengths & Weaknesses
Table 127. American Bio Medica Corp Basic Information, Manufacturing Base and Competitors
Table 128. American Bio Medica Corp Major Business
Table 129. American Bio Medica Corp Drugs of Abuse Analysis Controls Product and Services
Table 130. American Bio Medica Corp Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. American Bio Medica Corp Recent Developments/Updates
Table 132. American Bio Medica Corp Competitive Strengths & Weaknesses
Table 133. Clarity Diagnostics LLC Basic Information, Manufacturing Base and Competitors
Table 134. Clarity Diagnostics LLC Major Business
Table 135. Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Product and Services
Table 136. Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Clarity Diagnostics LLC Recent Developments/Updates
Table 138. Clarity Diagnostics LLC Competitive Strengths & Weaknesses
Table 139. Diatron Basic Information, Manufacturing Base and Competitors
Table 140. Diatron Major Business
Table 141. Diatron Drugs of Abuse Analysis Controls Product and Services
Table 142. Diatron Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Diatron Recent Developments/Updates
Table 144. Diatron Competitive Strengths & Weaknesses
Table 145. Kova International Basic Information, Manufacturing Base and Competitors
Table 146. Kova International Major Business
Table 147. Kova International Drugs of Abuse Analysis Controls Product and Services
Table 148. Kova International Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Kova International Recent Developments/Updates
Table 150. Kova International Competitive Strengths & Weaknesses
Table 151. Lin-Zhi International Inc Basic Information, Manufacturing Base and Competitors
Table 152. Lin-Zhi International Inc Major Business
Table 153. Lin-Zhi International Inc Drugs of Abuse Analysis Controls Product and Services
Table 154. Lin-Zhi International Inc Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Lin-Zhi International Inc Recent Developments/Updates
Table 156. Lin-Zhi International Inc Competitive Strengths & Weaknesses
Table 157. JAS Diagnostics Basic Information, Manufacturing Base and Competitors
Table 158. JAS Diagnostics Major Business
Table 159. JAS Diagnostics Drugs of Abuse Analysis Controls Product and Services
Table 160. JAS Diagnostics Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. JAS Diagnostics Recent Developments/Updates
Table 162. JAS Diagnostics Competitive Strengths & Weaknesses
Table 163. Quasar Instruments Basic Information, Manufacturing Base and Competitors
Table 164. Quasar Instruments Major Business
Table 165. Quasar Instruments Drugs of Abuse Analysis Controls Product and Services
Table 166. Quasar Instruments Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. Quasar Instruments Recent Developments/Updates
Table 168. Quasar Instruments Competitive Strengths & Weaknesses
Table 169. BTNX Basic Information, Manufacturing Base and Competitors
Table 170. BTNX Major Business
Table 171. BTNX Drugs of Abuse Analysis Controls Product and Services
Table 172. BTNX Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. BTNX Recent Developments/Updates
Table 174. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 175. Bio-Rad Laboratories Major Business
Table 176. Bio-Rad Laboratories Drugs of Abuse Analysis Controls Product and Services
Table 177. Bio-Rad Laboratories Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 178. Drugs of Abuse Analysis Controls Raw Material
Table 179. Key Manufacturers of Drugs of Abuse Analysis Controls Raw Materials
Table 180. Drugs of Abuse Analysis Controls Typical Distributors
Table 181. Drugs of Abuse Analysis Controls Typical Customers
Table 1. World Drugs of Abuse Analysis Controls Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Drugs of Abuse Analysis Controls Production Value by Region (2017-2022) & (USD Million)
Table 3. World Drugs of Abuse Analysis Controls Production Value by Region (2023-2028) & (USD Million)
Table 4. World Drugs of Abuse Analysis Controls Production Value Market Share by Region (2017-2022)
Table 5. World Drugs of Abuse Analysis Controls Production Value Market Share by Region (2023-2028)
Table 6. World Drugs of Abuse Analysis Controls Production by Region (2017-2022) & (K Units)
Table 7. World Drugs of Abuse Analysis Controls Production by Region (2023-2028) & (K Units)
Table 8. World Drugs of Abuse Analysis Controls Production Market Share by Region (2017-2022)
Table 9. World Drugs of Abuse Analysis Controls Production Market Share by Region (2023-2028)
Table 10. World Drugs of Abuse Analysis Controls Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Drugs of Abuse Analysis Controls Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Drugs of Abuse Analysis Controls Major Market Trends
Table 13. World Drugs of Abuse Analysis Controls Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Drugs of Abuse Analysis Controls Consumption by Region (2017-2022) & (K Units)
Table 15. World Drugs of Abuse Analysis Controls Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Drugs of Abuse Analysis Controls Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Drugs of Abuse Analysis Controls Producers in 2021
Table 18. World Drugs of Abuse Analysis Controls Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Drugs of Abuse Analysis Controls Producers in 2021
Table 20. World Drugs of Abuse Analysis Controls Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Drugs of Abuse Analysis Controls Company Evaluation Quadrant
Table 22. World Drugs of Abuse Analysis Controls Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Drugs of Abuse Analysis Controls Production Site of Key Manufacturer
Table 24. Drugs of Abuse Analysis Controls Market: Company Product Type Footprint
Table 25. Drugs of Abuse Analysis Controls Market: Company Product Application Footprint
Table 26. Drugs of Abuse Analysis Controls Competitive Factors
Table 27. Drugs of Abuse Analysis Controls New Entrant and Capacity Expansion Plans
Table 28. Drugs of Abuse Analysis Controls Mergers & Acquisitions Activity
Table 29. United States VS China Drugs of Abuse Analysis Controls Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Drugs of Abuse Analysis Controls Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Drugs of Abuse Analysis Controls Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Drugs of Abuse Analysis Controls in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Drugs of Abuse Analysis Controls Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Drugs of Abuse Analysis Controls Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Drugs of Abuse Analysis Controls in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Drugs of Abuse Analysis Controls Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Drugs of Abuse Analysis Controls Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Drugs of Abuse Analysis Controls in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Drugs of Abuse Analysis Controls Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Drugs of Abuse Analysis Controls Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Drugs of Abuse Analysis Controls Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Drugs of Abuse Analysis Controls Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Drugs of Abuse Analysis Controls Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Drugs of Abuse Analysis Controls Production by Type (2017-2022) & (K Units)
Table 49. World Drugs of Abuse Analysis Controls Production by Type (2023-2028) & (K Units)
Table 50. World Drugs of Abuse Analysis Controls Production Value by Type (2017-2022) & (USD Million)
Table 51. World Drugs of Abuse Analysis Controls Production Value by Type (2023-2028) & (USD Million)
Table 52. World Drugs of Abuse Analysis Controls Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Drugs of Abuse Analysis Controls Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Drugs of Abuse Analysis Controls Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Drugs of Abuse Analysis Controls Production by Application (2017-2022) & (K Units)
Table 56. World Drugs of Abuse Analysis Controls Production by Application (2023-2028) & (K Units)
Table 57. World Drugs of Abuse Analysis Controls Production Value by Application (2017-2022) & (USD Million)
Table 58. World Drugs of Abuse Analysis Controls Production Value by Application (2023-2028) & (USD Million)
Table 59. World Drugs of Abuse Analysis Controls Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Drugs of Abuse Analysis Controls Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Siemens Basic Information, Manufacturing Base and Competitors
Table 62. Siemens Major Business
Table 63. Siemens Drugs of Abuse Analysis Controls Product and Services
Table 64. Siemens Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Siemens Recent Developments/Updates
Table 66. Siemens Competitive Strengths & Weaknesses
Table 67. Abbott Basic Information, Manufacturing Base and Competitors
Table 68. Abbott Major Business
Table 69. Abbott Drugs of Abuse Analysis Controls Product and Services
Table 70. Abbott Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Abbott Recent Developments/Updates
Table 72. Abbott Competitive Strengths & Weaknesses
Table 73. QuidelOrtho Corporation Basic Information, Manufacturing Base and Competitors
Table 74. QuidelOrtho Corporation Major Business
Table 75. QuidelOrtho Corporation Drugs of Abuse Analysis Controls Product and Services
Table 76. QuidelOrtho Corporation Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. QuidelOrtho Corporation Recent Developments/Updates
Table 78. QuidelOrtho Corporation Competitive Strengths & Weaknesses
Table 79. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 80. Thermo Fisher Scientific Major Business
Table 81. Thermo Fisher Scientific Drugs of Abuse Analysis Controls Product and Services
Table 82. Thermo Fisher Scientific Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Thermo Fisher Scientific Recent Developments/Updates
Table 84. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 85. Horiba Basic Information, Manufacturing Base and Competitors
Table 86. Horiba Major Business
Table 87. Horiba Drugs of Abuse Analysis Controls Product and Services
Table 88. Horiba Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Horiba Recent Developments/Updates
Table 90. Horiba Competitive Strengths & Weaknesses
Table 91. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 92. Beckman Coulter Major Business
Table 93. Beckman Coulter Drugs of Abuse Analysis Controls Product and Services
Table 94. Beckman Coulter Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Beckman Coulter Recent Developments/Updates
Table 96. Beckman Coulter Competitive Strengths & Weaknesses
Table 97. Ortho Clinical Diagnostics Basic Information, Manufacturing Base and Competitors
Table 98. Ortho Clinical Diagnostics Major Business
Table 99. Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Product and Services
Table 100. Ortho Clinical Diagnostics Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Ortho Clinical Diagnostics Recent Developments/Updates
Table 102. Ortho Clinical Diagnostics Competitive Strengths & Weaknesses
Table 103. Microgenics Basic Information, Manufacturing Base and Competitors
Table 104. Microgenics Major Business
Table 105. Microgenics Drugs of Abuse Analysis Controls Product and Services
Table 106. Microgenics Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Microgenics Recent Developments/Updates
Table 108. Microgenics Competitive Strengths & Weaknesses
Table 109. MedTest DX Basic Information, Manufacturing Base and Competitors
Table 110. MedTest DX Major Business
Table 111. MedTest DX Drugs of Abuse Analysis Controls Product and Services
Table 112. MedTest DX Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. MedTest DX Recent Developments/Updates
Table 114. MedTest DX Competitive Strengths & Weaknesses
Table 115. Carolina Liquid Chemistries Basic Information, Manufacturing Base and Competitors
Table 116. Carolina Liquid Chemistries Major Business
Table 117. Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Product and Services
Table 118. Carolina Liquid Chemistries Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Carolina Liquid Chemistries Recent Developments/Updates
Table 120. Carolina Liquid Chemistries Competitive Strengths & Weaknesses
Table 121. Cerilliant Basic Information, Manufacturing Base and Competitors
Table 122. Cerilliant Major Business
Table 123. Cerilliant Drugs of Abuse Analysis Controls Product and Services
Table 124. Cerilliant Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Cerilliant Recent Developments/Updates
Table 126. Cerilliant Competitive Strengths & Weaknesses
Table 127. American Bio Medica Corp Basic Information, Manufacturing Base and Competitors
Table 128. American Bio Medica Corp Major Business
Table 129. American Bio Medica Corp Drugs of Abuse Analysis Controls Product and Services
Table 130. American Bio Medica Corp Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. American Bio Medica Corp Recent Developments/Updates
Table 132. American Bio Medica Corp Competitive Strengths & Weaknesses
Table 133. Clarity Diagnostics LLC Basic Information, Manufacturing Base and Competitors
Table 134. Clarity Diagnostics LLC Major Business
Table 135. Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Product and Services
Table 136. Clarity Diagnostics LLC Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Clarity Diagnostics LLC Recent Developments/Updates
Table 138. Clarity Diagnostics LLC Competitive Strengths & Weaknesses
Table 139. Diatron Basic Information, Manufacturing Base and Competitors
Table 140. Diatron Major Business
Table 141. Diatron Drugs of Abuse Analysis Controls Product and Services
Table 142. Diatron Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Diatron Recent Developments/Updates
Table 144. Diatron Competitive Strengths & Weaknesses
Table 145. Kova International Basic Information, Manufacturing Base and Competitors
Table 146. Kova International Major Business
Table 147. Kova International Drugs of Abuse Analysis Controls Product and Services
Table 148. Kova International Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Kova International Recent Developments/Updates
Table 150. Kova International Competitive Strengths & Weaknesses
Table 151. Lin-Zhi International Inc Basic Information, Manufacturing Base and Competitors
Table 152. Lin-Zhi International Inc Major Business
Table 153. Lin-Zhi International Inc Drugs of Abuse Analysis Controls Product and Services
Table 154. Lin-Zhi International Inc Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Lin-Zhi International Inc Recent Developments/Updates
Table 156. Lin-Zhi International Inc Competitive Strengths & Weaknesses
Table 157. JAS Diagnostics Basic Information, Manufacturing Base and Competitors
Table 158. JAS Diagnostics Major Business
Table 159. JAS Diagnostics Drugs of Abuse Analysis Controls Product and Services
Table 160. JAS Diagnostics Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. JAS Diagnostics Recent Developments/Updates
Table 162. JAS Diagnostics Competitive Strengths & Weaknesses
Table 163. Quasar Instruments Basic Information, Manufacturing Base and Competitors
Table 164. Quasar Instruments Major Business
Table 165. Quasar Instruments Drugs of Abuse Analysis Controls Product and Services
Table 166. Quasar Instruments Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. Quasar Instruments Recent Developments/Updates
Table 168. Quasar Instruments Competitive Strengths & Weaknesses
Table 169. BTNX Basic Information, Manufacturing Base and Competitors
Table 170. BTNX Major Business
Table 171. BTNX Drugs of Abuse Analysis Controls Product and Services
Table 172. BTNX Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. BTNX Recent Developments/Updates
Table 174. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 175. Bio-Rad Laboratories Major Business
Table 176. Bio-Rad Laboratories Drugs of Abuse Analysis Controls Product and Services
Table 177. Bio-Rad Laboratories Drugs of Abuse Analysis Controls Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 178. Drugs of Abuse Analysis Controls Raw Material
Table 179. Key Manufacturers of Drugs of Abuse Analysis Controls Raw Materials
Table 180. Drugs of Abuse Analysis Controls Typical Distributors
Table 181. Drugs of Abuse Analysis Controls Typical Customers
LIST OF FIGURES
Figure 1. Drugs of Abuse Analysis Controls Picture
Figure 2. World Drugs of Abuse Analysis Controls Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Drugs of Abuse Analysis Controls Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Drugs of Abuse Analysis Controls Production (2017-2028) & (K Units)
Figure 5. World Drugs of Abuse Analysis Controls Average Price (2017-2028) & (US$/Unit)
Figure 6. World Drugs of Abuse Analysis Controls Production Value Market Share by Region (2017-2028)
Figure 7. World Drugs of Abuse Analysis Controls Production Market Share by Region (2017-2028)
Figure 8. North America Drugs of Abuse Analysis Controls Production (2017-2028) & (K Units)
Figure 9. Europe Drugs of Abuse Analysis Controls Production (2017-2028) & (K Units)
Figure 10. China Drugs of Abuse Analysis Controls Production (2017-2028) & (K Units)
Figure 11. Japan Drugs of Abuse Analysis Controls Production (2017-2028) & (K Units)
Figure 12. Drugs of Abuse Analysis Controls Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Drugs of Abuse Analysis Controls Demand (2017-2028) & (K Units)
Figure 15. World Drugs of Abuse Analysis Controls Consumption Market Share by Region (2017-2028)
Figure 16. United States Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 17. China Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 18. Europe Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 19. Japan Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 20. South Korea Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 22. India Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Drugs of Abuse Analysis Controls by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Drugs of Abuse Analysis Controls Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Drugs of Abuse Analysis Controls Markets in 2021
Figure 26. United States VS China: Drugs of Abuse Analysis Controls Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Drugs of Abuse Analysis Controls Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Drugs of Abuse Analysis Controls Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Drugs of Abuse Analysis Controls in United States
Figure 30. Key Producers and Market Share of Drugs of Abuse Analysis Controls in China
Figure 31. Key Producers and Market Share of Drugs of Abuse Analysis Controls in Rest of World
Figure 32. World Drugs of Abuse Analysis Controls Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Drugs of Abuse Analysis Controls Production Value Market Share by Type in 2021
Figure 34. Liquid
Figure 35. Lyophilized
Figure 36. Others
Figure 37. World Drugs of Abuse Analysis Controls Production Market Share by Type (2017-2028)
Figure 38. World Drugs of Abuse Analysis Controls Production Value Market Share by Type (2017-2028)
Figure 39. World Drugs of Abuse Analysis Controls Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Drugs of Abuse Analysis Controls Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Drugs of Abuse Analysis Controls Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Clinical
Figure 44. Diagnostic Laboratories
Figure 45. Others
Figure 46. World Drugs of Abuse Analysis Controls Production Market Share by Application (2017-2028)
Figure 47. World Drugs of Abuse Analysis Controls Production Value Market Share by Application (2017-2028)
Figure 48. World Drugs of Abuse Analysis Controls Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of Drugs of Abuse Analysis Controls in 2021
Figure 50. Manufacturing Process Analysis of Drugs of Abuse Analysis Controls
Figure 51. Drugs of Abuse Analysis Controls Industrial Chain
Figure 52. Distribution Channel Breakdown for Drugs of Abuse Analysis Controls Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Drugs of Abuse Analysis Controls Picture
Figure 2. World Drugs of Abuse Analysis Controls Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Drugs of Abuse Analysis Controls Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Drugs of Abuse Analysis Controls Production (2017-2028) & (K Units)
Figure 5. World Drugs of Abuse Analysis Controls Average Price (2017-2028) & (US$/Unit)
Figure 6. World Drugs of Abuse Analysis Controls Production Value Market Share by Region (2017-2028)
Figure 7. World Drugs of Abuse Analysis Controls Production Market Share by Region (2017-2028)
Figure 8. North America Drugs of Abuse Analysis Controls Production (2017-2028) & (K Units)
Figure 9. Europe Drugs of Abuse Analysis Controls Production (2017-2028) & (K Units)
Figure 10. China Drugs of Abuse Analysis Controls Production (2017-2028) & (K Units)
Figure 11. Japan Drugs of Abuse Analysis Controls Production (2017-2028) & (K Units)
Figure 12. Drugs of Abuse Analysis Controls Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Drugs of Abuse Analysis Controls Demand (2017-2028) & (K Units)
Figure 15. World Drugs of Abuse Analysis Controls Consumption Market Share by Region (2017-2028)
Figure 16. United States Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 17. China Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 18. Europe Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 19. Japan Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 20. South Korea Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 22. India Drugs of Abuse Analysis Controls Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Drugs of Abuse Analysis Controls by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Drugs of Abuse Analysis Controls Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Drugs of Abuse Analysis Controls Markets in 2021
Figure 26. United States VS China: Drugs of Abuse Analysis Controls Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Drugs of Abuse Analysis Controls Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Drugs of Abuse Analysis Controls Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Drugs of Abuse Analysis Controls in United States
Figure 30. Key Producers and Market Share of Drugs of Abuse Analysis Controls in China
Figure 31. Key Producers and Market Share of Drugs of Abuse Analysis Controls in Rest of World
Figure 32. World Drugs of Abuse Analysis Controls Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Drugs of Abuse Analysis Controls Production Value Market Share by Type in 2021
Figure 34. Liquid
Figure 35. Lyophilized
Figure 36. Others
Figure 37. World Drugs of Abuse Analysis Controls Production Market Share by Type (2017-2028)
Figure 38. World Drugs of Abuse Analysis Controls Production Value Market Share by Type (2017-2028)
Figure 39. World Drugs of Abuse Analysis Controls Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Drugs of Abuse Analysis Controls Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Drugs of Abuse Analysis Controls Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Clinical
Figure 44. Diagnostic Laboratories
Figure 45. Others
Figure 46. World Drugs of Abuse Analysis Controls Production Market Share by Application (2017-2028)
Figure 47. World Drugs of Abuse Analysis Controls Production Value Market Share by Application (2017-2028)
Figure 48. World Drugs of Abuse Analysis Controls Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of Drugs of Abuse Analysis Controls in 2021
Figure 50. Manufacturing Process Analysis of Drugs of Abuse Analysis Controls
Figure 51. Drugs of Abuse Analysis Controls Industrial Chain
Figure 52. Distribution Channel Breakdown for Drugs of Abuse Analysis Controls Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
